SLCO1B1 c.1387_1388delinsGC ;(p.C463A)

Variant ID: 12-21358857-TG-GC

NM_006446.4(SLCO1B1):c.1387_1388delinsGC;(p.C463A)

This variant was identified in 7 publications

View GRCh38 version.




Publications:


The influence of genetic polymorphisms in drug metabolism enzymes and transporters on the pharmacokinetics of different fluvastatin formulations.

Asian Journal Of Pharmaceutical Sciences
Xiang, Qian Q; Wu, Weidang W; Zhao, Nan N; Li, Chuan C; Xu, Junyu J; Ma, Lingyue L; Zhang, Xiaodan X; Xie, Qiufen Q; Zhang, Zhuo Z; Wang, Jiancheng J; Xu, Weiren W; Zhao, Xia X; Cui, Yimin Y
Publication Date: 2020-03

Variant appearance in text: SLCO1B1: C463A
PubMed Link: 32373204
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page



Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB.

The Journal Of Antimicrobial Chemotherapy
Vinnard, Christopher C; Ravimohan, Shruthi S; Tamuhla, Neo N; Pasipanodya, Jotam J; Srivastava, Shashikant S; Modongo, Chawangwa C; Zetola, Nicola M NM; Weissman, Drew D; Gumbo, Tawanda T; Bisson, Gregory P GP
Publication Date: 2017-07-01

Variant appearance in text: SLCO1B1: C463A
PubMed Link: 28472448
Variant Present in the following documents:
  • Main text
View BVdb publication page



Quantitative targeted proteomics for membrane transporter proteins: method and application.

The Aaps Journal
Qiu, Xi X; Zhang, Hui H; Lai, Yurong Y
Publication Date: 2014-07

Variant appearance in text: SLCO1B1: C463A
PubMed Link: 24830943
Variant Present in the following documents:
  • Main text
View BVdb publication page



Association of CYP2C9*2 with bosentan-induced liver injury.

Clinical Pharmacology And Therapeutics
Markova, S M SM; De Marco, T T; Bendjilali, N N; Kobashigawa, E A EA; Mefford, J J; Sodhi, J J; Le, H H; Zhang, C C; Halladay, J J; Rettie, A E AE; Khojasteh, C C; McGlothlin, D D; Wu, A H B AH; Hsueh, W-C WC; Witte, J S JS; Schwartz, J B JB; Kroetz, D L DL
Publication Date: 2013-12

Variant appearance in text: OATP1B1: C463A
PubMed Link: 23863877
Variant Present in the following documents:
  • Main text
View BVdb publication page



The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications.

Antimicrobial Agents And Chemotherapy
Chigutsa, Emmanuel E; Visser, Marianne E ME; Swart, Elizabeth C EC; Denti, Paolo P; Pushpakom, Sudeep S; Egan, Deirdre D; Holford, Nicholas H G NH; Smith, Peter J PJ; Maartens, Gary G; Owen, Andrew A; McIlleron, Helen H
Publication Date: 2011-09

Variant appearance in text: SLCO1B1: C463A
PubMed Link: 21709081
Variant Present in the following documents:
  • Main text
View BVdb publication page



Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

Pharmacological Reviews
Klaassen, Curtis D CD; Aleksunes, Lauren M LM
Publication Date: 2010-03

Variant appearance in text: OATP1B1: C463A
PubMed Link: 20103563
Variant Present in the following documents:
  • Main text
View BVdb publication page



The role of organic anion-transporting polypeptides and their common genetic variants in mycophenolic acid pharmacokinetics.

Clinical Pharmacology And Therapeutics
Picard, N N; Yee, S W SW; Woillard, J-B JB; Lebranchu, Y Y; Le Meur, Y Y; Giacomini, K M KM; Marquet, P P
Publication Date: 2010-01

Variant appearance in text: SLCO1B1: C463A
PubMed Link: 19890249
Variant Present in the following documents:
  • Main text
View BVdb publication page